NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $16,170,000 | -28.7% | 200 | -25.9% | 0.02% | -12.5% |
| Q4 2017 | $22,669,000 | -59.3% | 270 | -58.4% | 0.02% | -64.7% |
| Q3 2017 | $55,716,000 | +327.9% | 649 | +316.0% | 0.07% | +353.3% |
| Q2 2017 | $13,021,000 | +12.4% | 156 | 0.0% | 0.02% | +15.4% |
| Q1 2017 | $11,586,000 | +2.0% | 156 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $11,363,000 | -7.7% | 156 | 0.0% | 0.01% | +44.4% |
| Q3 2016 | $12,317,000 | -4.3% | 156 | 0.0% | 0.01% | -47.1% |
| Q2 2016 | $12,871,000 | +13.9% | 156 | 0.0% | 0.02% | +21.4% |
| Q1 2016 | $11,300,000 | -82.2% | 156 | -78.8% | 0.01% | -81.3% |
| Q4 2015 | $63,411,000 | +118.3% | 737 | +133.2% | 0.08% | +25.0% |
| Q3 2015 | $29,047,000 | +195.4% | 316 | +216.0% | 0.06% | +566.7% |
| Q2 2015 | $9,834,000 | -0.3% | 100 | 0.0% | 0.01% | -10.0% |
| Q1 2015 | $9,861,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |